CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$1.28+0.09 (+7.56%)

Close on Nov 13, 2026Market cap $22.51MP/E –Yield –

Cel Sci EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cel Sci has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?